Loading…

Balloon mitral valvuloplasty in low gradient severe rheumatic mitral stenosis: Immediate and short-term outcomes

•Treatment and effectiveness of BMV in low gradient severe MS is not well defined.•Only retrospective study by El Sabbagh was in older western population (>65 years)•This is first prospective study defining benefits of BMV in LG severe rheumatic MS.•Symptomatic improvement was better seen in NFLG...

Full description

Saved in:
Bibliographic Details
Published in:International journal of cardiology. Heart & vasculature 2024-04, Vol.51, p.101394-101394, Article 101394
Main Authors: Yusuf, Jamal, Kumar Chaudhary, Manny, Muheeb, Ghazi, Mehta, Vimal, Mukhopadhyay, Saibal
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:•Treatment and effectiveness of BMV in low gradient severe MS is not well defined.•Only retrospective study by El Sabbagh was in older western population (>65 years)•This is first prospective study defining benefits of BMV in LG severe rheumatic MS.•Symptomatic improvement was better seen in NFLG group compared to LFLG group.•BMV should be the treatment of choice for NFLG severe rheumatic MS. Efficacy of balloon mitral valvuloplasty (BMV) in low gradient severe rheumatic mitral stenosis (MS) is not very well defined. This study was undertaken to evaluate the outcomes of BMV in low gradient severe rheumatic MS. Severe MS was defined as mitral valve area 
ISSN:2352-9067
2352-9067
DOI:10.1016/j.ijcha.2024.101394